Our previous report also showed that MKI-1 inhibited MASTL with in vitro IC50 of 9.9 μM and reduced phosphorylated ENSA with the induction of aberrant nuclear cells in breast cancer cells [22]. The gene discussed is MASTL; the disease is breast cancer.